![]() PQ Bypass PQ Bypass is a medical device company, which aims to transform the treatment of long-segment femoropopliteal disease. | ![]() CarThera CarThera is a technology company which designs and develops therapeutic ultrasound-based medical devices for treating brain disorders. | ![]() H-CYTE H-CYTE (formerly known as Medovex) builds and develops medical technology products and services. | ![]() EBR Systems EBR Systems is driven to deliver treatment for millions of patients suffering from cardiac rhythm diseases by developing safe, clinical, cost-effective and reliable therapies using wireless cardiac stimulation. | ||
Founding Date | Founding Date 2018 | Founding Date 2009 | Founding Date 2010 | Founding Date 2013 | Founding Date 2003 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Doughiska, IE HQ | Locations Milpitas, US HQ | Locations Paris, FR HQ Lyon, FR Paris, FR Boston, US | Locations Tampa, US HQ | Locations Sunnyvale, US HQ |
Employees | Employees 38 | Employees 564% decrease | Employees 346% decrease | Employees 650% decrease | Employees 1085% increase |
Funding | |||||
Latest funding round | Latest funding round $ 3.4m (over 7 years ago) | Latest funding round $ 60m (over 7 years ago) | Latest funding round $ 10.2m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 30m (over 6 years ago) |
Total funding raised | Total funding raised $ 3.4m | Total funding raised $ 70m | Total funding raised $ 16.5m | Total funding raised $ 6m | Total funding raised $ 199.9m |

PQ Bypass is a medical device company, which aims to transform the treatment of long-segment femoropopliteal disease.
View company
CarThera is a technology company which designs and develops therapeutic ultrasound-based medical devices for treating brain disorders.
View company
H-CYTE (formerly known as Medovex) builds and develops medical technology products and services.
View company
EBR Systems is driven to deliver treatment for millions of patients suffering from cardiac rhythm diseases by developing safe, clinical, cost-effective and reliable therapies using wireless cardiac stimulation.
View company